These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20714305)

  • 1. Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening.
    García I; Fall Y; Gómez G
    Molecules; 2010 Aug; 15(8):5408-22. PubMed ID: 20714305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.
    García I; Fall Y; Gómez G; González-Díaz H
    Mol Divers; 2011 May; 15(2):561-7. PubMed ID: 20931280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR, docking, and CoMFA studies of GSK3 inhibitors.
    García I; Fall Y; Gómez G
    Curr Pharm Des; 2010; 16(24):2666-75. PubMed ID: 20642432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.
    Osolodkin DI; Zakharevich NV; Palyulin VA; Danilenko VN; Zefirov NS
    Parasitology; 2011 May; 138(6):725-35. PubMed ID: 21349219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical study of GSK-3α: neural networks QSAR studies for the design of new inhibitors using 2D descriptors.
    García I; Fall Y; García-Mera X; Prado-Prado F
    Mol Divers; 2011 Nov; 15(4):947-55. PubMed ID: 21735119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
    González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
    Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling of the inhibition of glycogen synthase kinase-3.
    Katritzky AR; Pacureanu LM; Dobchev DA; Fara DC; Duchowicz PR; Karelson M
    Bioorg Med Chem; 2006 Jul; 14(14):4987-5002. PubMed ID: 16650999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease.
    Medina M; Avila J
    Curr Pharm Des; 2010; 16(25):2790-8. PubMed ID: 20698823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
    He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
    Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new protocol for predicting novel GSK-3β ATP competitive inhibitors.
    Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J
    J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR studies for the pharmacological inhibition of glycogen synthase kinase-3.
    Duchowicz PR; Castro EA
    Med Chem; 2007 Jul; 3(4):393-417. PubMed ID: 17627578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.
    Saraswati AP; Ali Hussaini SM; Krishna NH; Babu BN; Kamal A
    Eur J Med Chem; 2018 Jan; 144():843-858. PubMed ID: 29306837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3 inhibitors for Alzheimer's disease.
    Avila J; Hernández F
    Expert Rev Neurother; 2007 Nov; 7(11):1527-33. PubMed ID: 17997701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and synthetic bioactive inhibitors of glycogen synthase kinase.
    Khan I; Tantray MA; Alam MS; Hamid H
    Eur J Med Chem; 2017 Jan; 125():464-477. PubMed ID: 27689729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease.
    Noh MY; Chun K; Kang BY; Kim H; Park JS; Lee HC; Kim YH; Ku S; Kim SH
    Biochem Biophys Res Commun; 2013 May; 435(2):274-81. PubMed ID: 23632329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors.
    Ermondi G; Caron G; Pintos IG; Gerbaldo M; Pérez M; Pérez DI; Gándara Z; Martínez A; Gómez G; Fall Y
    Eur J Med Chem; 2011 Mar; 46(3):860-9. PubMed ID: 21281991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First report on exploring classification and regression based QSAR modelling of Plasmodium falciparum glycogen synthase kinase (PfGSK-3) inhibitors.
    Balasaheb Aher R; Roy K
    SAR QSAR Environ Res; 2015; 26(11):959-76. PubMed ID: 26524390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Prado-Prado FJ; García-Mera X; González-Díaz H
    Bioorg Med Chem; 2010 Mar; 18(6):2225-2231. PubMed ID: 20185316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.